assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_002346045.1_ASM234604v1	NZ_CP009930	Burkholderia mallei strain FMH chromosome 2, complete sequence	1	2198921-2199013	1	CRISPRCasFinder	no		cas3,csa3	Orphan	GCGCGTCGGCGCGCGCGGCGGCGA	24	0	0	NA	NA	NA	1	1	Orphan	DEDDh,csa3,DinG,WYL,cas3	NA|53aa|up_6|NZ_CP009930.1_2190884_2191043_+,NA|170aa|up_4|NZ_CP009930.1_2193240_2193750_+,NA|168aa|up_3|NZ_CP009930.1_2193807_2194311_-,NA|86aa|down_6|NZ_CP009930.1_2202984_2203242_+	NA|1072aa|up_9|NZ_CP009930.1_2184463_2187679_+	COG1131, CcmA, ABC-type multidrug transport system, ATPase component [Defense mechanisms]	NA|375aa|up_8|NZ_CP009930.1_2187681_2188806_+	COG0842, COG0842, ABC-type multidrug transport system, permease component [Defense mechanisms]	NA|612aa|up_7|NZ_CP009930.1_2188955_2190791_+	PRK13557, PRK13557, histidine kinase; Provisional	NA|53aa|up_6|NZ_CP009930.1_2190884_2191043_+	NA	NA|535aa|up_5|NZ_CP009930.1_2191134_2192739_-	PRK15048, PRK15048, methyl-accepting chemotaxis protein II; Provisional	NA|170aa|up_4|NZ_CP009930.1_2193240_2193750_+	NA	NA|168aa|up_3|NZ_CP009930.1_2193807_2194311_-	NA	NA|342aa|up_2|NZ_CP009930.1_2194387_2195413_-	cd08297, CAD3, Cinnamyl alcohol dehydrogenases (CAD)	NA|283aa|up_1|NZ_CP009930.1_2195627_2196476_-	pfam00231, ATP-synt, ATP synthase	NA|671aa|up_0|NZ_CP009930.1_2196472_2198485_-	PRK13343, PRK13343, F0F1 ATP synthase subunit alpha; Provisional	NA|83aa|down_0|NZ_CP009930.1_2199231_2199480_-	PRK13468, PRK13468, F0F1 ATP synthase subunit C; Provisional	NA|234aa|down_1|NZ_CP009930.1_2199476_2200178_-	PRK13421, PRK13421, F0F1 ATP synthase subunit A; Provisional	NA|103aa|down_2|NZ_CP009930.1_2200174_2200483_-	TIGR03165, F1F0_chp_2, F1/F0 ATPase, Methanosarcina type, subunit 2	NA|164aa|down_3|NZ_CP009930.1_2200475_2200967_-	pfam09527, ATPase_gene1, Putative F0F1-ATPase subunit Ca2+/Mg2+ transporter	NA|152aa|down_4|NZ_CP009930.1_2200963_2201419_-	PRK13447, PRK13447, F0F1 ATP synthase subunit epsilon; Provisional	NA|535aa|down_5|NZ_CP009930.1_2201408_2203013_-	PRK12597, PRK12597, F0F1 ATP synthase subunit beta; Provisional	NA|86aa|down_6|NZ_CP009930.1_2202984_2203242_+	NA	NA|598aa|down_7|NZ_CP009930.1_2203373_2205167_+	TIGR01838, Poly-beta-hydroxybutyrate_polymerase, poly(R)-hydroxyalkanoic acid synthase, class I	NA|477aa|down_8|NZ_CP009930.1_2205150_2206581_+	PRK08190, PRK08190, bifunctional enoyl-CoA hydratase/phosphate acetyltransferase; Validated	NA|393aa|down_9|NZ_CP009930.1_2206577_2207756_+	PRK07058, PRK07058, acetate/propionate family kinase
